Shanghai Kehua Bio-engineering (002022.SZ): Norovirus G and G Nucleic Acid Typing Detection Kit (Fluorescence PCR Method) obtained medical device registration certificate.
Shanghai Kehua Bio-engineering (002022.SZ) announced that recently, its controlling subsidiary Suzhou Tianlong Biotechnology Co., Ltd. received a medical device registration certificate (in vitro diagnostic reagent) issued by the National Medical Products Administration. The product is: "Norovirus G and G Nucleic Acid Typing Detection Kit (Fluorescence PCR Method)". This kit is used for in vitro qualitative typing detection of Norovirus G and G nucleic acid RNA in stool samples.
Shanghai Kehua Bio-engineering (002022.SZ) announced that recently, its controlling subsidiary Suzhou Tianlong Biotechnology Co., Ltd. received a medical device registration certificate (in vitro diagnostic reagent) issued by the National Medical Products Administration. The product is: "Norovirus G and G Nucleic Acid Typing Detection Kit (Fluorescence PCR Method)". This kit is used for in vitro qualitative typing detection of Norovirus G and G nucleic acid RNA in stool samples.
Related Articles
Midea Group Co., Ltd (00300) repurchased 1,075,300 A shares on October 12 for approximately RMB 89.9143 million.
ESSEX BIO-TECH (01061) repurchased 30,000 shares for HK$61,800 on October 12.
CHINA HONGBAO (08316) changes its name to "Sujiao Suidao Life Holdings Limited"
Midea Group Co., Ltd (00300) repurchased 1,075,300 A shares on October 12 for approximately RMB 89.9143 million.
ESSEX BIO-TECH (01061) repurchased 30,000 shares for HK$61,800 on October 12.
CHINA HONGBAO (08316) changes its name to "Sujiao Suidao Life Holdings Limited"
